NexgenRx Announces Option Grant

NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) announces the
grant to certain directors, officers and employees of NexgenRx of an aggregate
of 1,015,000 options to acquire common shares in the capital of NexgenRx at a
price of $0.22 for 5 years (vesting as to 20% each year for four years,
beginning on the first anniversary of the grant date, and the final 20% on the
date that is 90 days prior to the fifth anniversary of the grant date). The
foregoing options grant is subject to final regulatory approval.


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com.


Caution Regarding Forward-Looking Statements - This news release contains
certain forward looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393x803